Dagmar proposals unfeasible and hanging on a thread?
This article was originally published in Clinica
Executive Summary
The more I think about it and the more I talk to others in the medical devices sector about European Parliament rapporteur Dagmar Roth-Behrendt’s proposals for centralised marketing authorisation by a new committee within the EMA and decentralised authorisation for some devices, the more convinced I am that her suggestions are unfeasible.
You may also be interested in...
EU Experts Want One-Stop-Shop EU Governance That Mimics Best Of Other Jurisdictions
It may be blue sky thinking to surmise how a new EU medtech regulatory governance structure could evolve. But with change on the horizon, experts see exciting opportunities.
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
EU Regulatory Experts Support Notified Bodies, But Argue For Greater Consistency
Notified bodies have been a pivotal part of the EU medtech regulatory system since it was first launched in the 1990s. Where might they fit within a new medtech regulatory governance structure? Panelists on a recent vodcast grappled with the question.